ℹ️
🇬🇧
Search
Search for people relevant for "adduct formation"
adduct formation
Person
Class
Person
Publication
Programmes
Export current view
RNDr. Jitka Poljaková Ph.D.
Academic staff at Faculty of Science
39 publications
Publications
publication
Electrochemical Determination of Enzymes Metabolizing Ellipticine in Thyroid Cancer Cells - a Tool to Explain the Mechanism of Ellipticine Toxicity to these Cells
2013 |
Faculty of Science, Second Faculty of Medicine
publication
Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5
2012 |
Faculty of Science
publication
Ellipticine cytotoxicity to cancer cell lines - a comparative study
2011 |
Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
publication
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
2009 |
Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
publication
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
2007 |
Faculty of Science, Second Faculty of Medicine
publication
Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells
2007 |
Faculty of Science
publication
The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine
2006 |
Faculty of Science
publication
Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Peroxidase and CYP-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
First Faculty of Medicine, Faculty of Mathematics and Physics
publication
Peroxidase-mediated ellipticine-DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia
2003 |
Faculty of Science
Load more publications (29)
Loading network view...